selection of high risk pharmaceutical products (PPs)
application of novel cleanup, concentration and diagnostic
methods as well as HTSAs for monitoring PPs in environmental, food and
human patient samples
studies of the mechanisms of action of high risk PPs in vitro, in situ and in vivo
monitoring fecundity problems in target populations in relation to dietary habits (epidemiological study)
development of risk management strategies
establishment of web based knowledge pools, publication and communication of data
